Filing Details

Accession Number:
0001415889-24-007242
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-07 21:40:13
Reporting Period:
2024-02-29
Accepted Time:
2024-03-07 21:40:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2010135 John Fesko C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
President, Chief Bus. Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-29 3,607 $0.00 114,501 No 4 A Direct
Common Stock Disposition 2024-03-05 15 $87.37 114,486 No 4 S Direct
Common Stock Disposition 2024-03-05 1,823 $88.37 112,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 14,429 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,607 shares of Common Stock was certified.
  2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.